FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017337073> ?p ?o ?g. }

• W2017337073 endingPage "161" @default.
• W2017337073 startingPage "161" @default.
• W2017337073 abstract "<h3>Importance</h3> Hypertension is prevalent among patients with psoriasis. The effect of psoriasis and its severity on hypertension control is unknown. <h3>Objective</h3> To determine the association between uncontrolled blood pressure and psoriasis, both overall and according to objectively measured psoriasis severity, among patients with diagnosed hypertension. <h3>Design, Setting, and Participants</h3> Population-based cross-sectional study nested in a prospective cohort drawn from The Health Improvement Network (THIN), an electronic medical records database broadly representative of the general population in the United Kingdom. The study population included a random sample of patients with psoriasis (n = 1322) between the ages of 25 and 64 years in THIN who were included in the Incident Health Outcomes and Psoriasis Events prospective cohort and their age- and practice-matched controls without psoriasis (n = 11 977). All included patients had a diagnosis of hypertension; their psoriasis diagnosis was confirmed and disease severity was classified by their general practitioners. <h3>Main Outcomes and Measures</h3> Uncontrolled hypertension was defined as a systolic blood pressure of 140 mm Hg or higher or a diastolic blood pressure of 90 mm Hg or higher based on the blood pressure recorded closest in time to the assessment of psoriasis severity. <h3>Results</h3> There was a significant positive dose-response relationship between uncontrolled hypertension and psoriasis severity as objectively determined by the affected body surface area in both unadjusted and adjusted analyses that controlled for age, sex, body mass index, smoking and alcohol use status, presence of comorbid conditions, and current use of antihypertensive medications and nonsteroidal anti-inflammatory drugs (adjusted odds ratio [aOR], 0.97; 95% CI, 0.82-1.14 for mild psoriasis; aOR, 1.20; 95% CI, 0.99-1.45 for moderate psoriasis; and aOR, 1.48; 95% CI, 1.08-2.04 for severe psoriasis;<i>P</i> = .01 for trend). The likelihood of uncontrolled hypertension among psoriasis overall was also increased, although not statistically significantly so (aOR, 1.10; 95% CI, 0.98-1.24). <h3>Conclusions and Relevance</h3> Among patients with hypertension, psoriasis was associated with a greater likelihood of uncontrolled hypertension in a dose-dependent manner, with the greatest likelihood observed among those with moderate to severe psoriasis defined by 3% or more of the body surface area affected. Our data suggest a need for more effective blood pressure management, particularly among patients with more severe psoriasis." @default.
• W2017337073 created "2016-06-24" @default.
• W2017337073 creator A5003671711 @default.
• W2017337073 creator A5027555412 @default.
• W2017337073 creator A5037356234 @default.
• W2017337073 creator A5039751986 @default.
• W2017337073 creator A5043481396 @default.
• W2017337073 creator A5047049575 @default.
• W2017337073 creator A5057661348 @default.
• W2017337073 creator A5088116210 @default.
• W2017337073 date "2015-02-01" @default.
• W2017337073 modified "2023-10-12" @default.
• W2017337073 title "Effect of Psoriasis Severity on Hypertension Control" @default.
• W2017337073 cites W1515251814 @default.
• W2017337073 cites W1521074138 @default.
• W2017337073 cites W1540124901 @default.
• W2017337073 cites W1965627478 @default.
• W2017337073 cites W1977207218 @default.
• W2017337073 cites W1983661880 @default.
• W2017337073 cites W1985886453 @default.
• W2017337073 cites W1986765542 @default.
• W2017337073 cites W1993884221 @default.
• W2017337073 cites W1998185987 @default.
• W2017337073 cites W2005240397 @default.
• W2017337073 cites W2014771215 @default.
• W2017337073 cites W2019270353 @default.
• W2017337073 cites W2022665587 @default.
• W2017337073 cites W2024149425 @default.
• W2017337073 cites W2028621745 @default.
• W2017337073 cites W2047354818 @default.
• W2017337073 cites W2051826678 @default.
• W2017337073 cites W2056468769 @default.
• W2017337073 cites W2057014857 @default.
• W2017337073 cites W2063761073 @default.
• W2017337073 cites W2066752983 @default.
• W2017337073 cites W2068529294 @default.
• W2017337073 cites W2068955201 @default.
• W2017337073 cites W2070247357 @default.
• W2017337073 cites W2078157933 @default.
• W2017337073 cites W2088078494 @default.
• W2017337073 cites W2089781923 @default.
• W2017337073 cites W2095652983 @default.
• W2017337073 cites W2096517093 @default.
• W2017337073 cites W2103120331 @default.
• W2017337073 cites W2105477284 @default.
• W2017337073 cites W2123161518 @default.
• W2017337073 cites W2126236710 @default.
• W2017337073 cites W2126862979 @default.
• W2017337073 cites W2131430597 @default.
• W2017337073 cites W2132733717 @default.
• W2017337073 cites W2145677448 @default.
• W2017337073 cites W2153626991 @default.
• W2017337073 cites W2155121555 @default.
• W2017337073 cites W2156121263 @default.
• W2017337073 cites W2157118376 @default.
• W2017337073 cites W2169476735 @default.
• W2017337073 cites W2320426359 @default.
• W2017337073 cites W88373170 @default.
• W2017337073 doi "https://doi.org/10.1001/jamadermatol.2014.2094" @default.
• W2017337073 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4728300" @default.
• W2017337073 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25322196" @default.
• W2017337073 hasPublicationYear "2015" @default.
• W2017337073 type Work @default.
• W2017337073 sameAs 2017337073 @default.
• W2017337073 citedByCount "76" @default.
• W2017337073 countsByYear W20173370732015 @default.
• W2017337073 countsByYear W20173370732016 @default.
• W2017337073 countsByYear W20173370732017 @default.
• W2017337073 countsByYear W20173370732018 @default.
• W2017337073 countsByYear W20173370732019 @default.
• W2017337073 countsByYear W20173370732020 @default.
• W2017337073 countsByYear W20173370732021 @default.
• W2017337073 countsByYear W20173370732022 @default.
• W2017337073 countsByYear W20173370732023 @default.
• W2017337073 crossrefType "journal-article" @default.
• W2017337073 hasAuthorship W2017337073A5003671711 @default.
• W2017337073 hasAuthorship W2017337073A5027555412 @default.
• W2017337073 hasAuthorship W2017337073A5037356234 @default.
• W2017337073 hasAuthorship W2017337073A5039751986 @default.
• W2017337073 hasAuthorship W2017337073A5043481396 @default.
• W2017337073 hasAuthorship W2017337073A5047049575 @default.
• W2017337073 hasAuthorship W2017337073A5057661348 @default.
• W2017337073 hasAuthorship W2017337073A5088116210 @default.
• W2017337073 hasBestOaLocation W20173370732 @default.
• W2017337073 hasConcept C126322002 @default.
• W2017337073 hasConcept C16005928 @default.
• W2017337073 hasConcept C188816634 @default.
• W2017337073 hasConcept C201903717 @default.
• W2017337073 hasConcept C2777011040 @default.
• W2017337073 hasConcept C2777501473 @default.
• W2017337073 hasConcept C2780221984 @default.
• W2017337073 hasConcept C2780564577 @default.
• W2017337073 hasConcept C2908647359 @default.
• W2017337073 hasConcept C71924100 @default.
• W2017337073 hasConcept C72563966 @default.
• W2017337073 hasConcept C84393581 @default.
• W2017337073 hasConcept C99454951 @default.
• W2017337073 hasConceptScore W2017337073C126322002 @default.

• next